Yeast Infection Treatment Online in Vermont

TeleDirectMD operates as a cash-pay practice in Vermont. Your $79 visit fee is paid at booking. Prescription costs are filled separately at your pharmacy and may be covered by your pharmacy benefit. HSA and FSA cards are accepted. There is no insurance billing in Vermont — straightforward, transparent pricing.

Yes. 18 V.S.A. Chapter 219 (Vermont's telemedicine statute) — permits Vermont-licensed physicians to diagnose and treat uncomplicated vulvovaginal candidiasis (VVC) by synchronous video visit without a prior in-person examination. The Vermont Board of Medical Practice holds telehealth physicians to the same standard of care as in-person physicians. Classic VVC symptoms — thick white discharge, vaginal itching, and vulvar irritation without odor, fever, or systemic illness — can be reliably evaluated by history. Per ACOG Practice Bulletin 215, empiric oral fluconazole 150 mg is appropriate for women with classic VVC symptoms who have previously been diagnosed. TeleDirectMD self pay is $79.

No. 18 V.S.A. Chapter 219 does not require a prior in-person visit. A Vermont-licensed physician can establish a new patient relationship and prescribe appropriate non-controlled medications — including fluconazole — through a synchronous video visit after obtaining informed consent. Verbal or written consent is documented at the start of every TeleDirectMD visit.

Vulvovaginal candidiasis (VVC) affects an estimated 75% of women at least once in their lifetime and approximately 40–45% experience recurrent infections, according to the American College of Obstetricians and Gynecologists. With Vermont's population of approximately 20 million women, this translates to millions experiencing VVC annually. Most infections are caused by Candida albicans, which is susceptible to standard azole therapy. Non-albicans species — more common after repeated treatment — require culture-guided therapy from an in-person provider.

Both conditions cause vaginal discharge and discomfort, but they are distinct. Yeast infection (VVC) typically causes thick, white, cottage cheese-like discharge with vulvar itching and burning; there is no odor. Bacterial vaginosis (BV) causes thin, grayish or white discharge with a characteristic fishy odor, and is caused by overgrowth of anaerobic bacteria rather than fungal overgrowth. The CDC STI Treatment Guidelines treat these as separate conditions requiring different medications — azoles for VVC, metronidazole or clindamycin for BV. If symptoms are uncertain, in-person testing with microscopy (wet prep) can differentiate the two.

Per ACOG Practice Bulletin 215 (2020), first-line treatment for uncomplicated VVC includes: oral fluconazole 150 mg single dose (GoodRx ~$11.92 / 2 tablets at goodrx.com), or OTC intravaginal azoles — miconazole 2% cream ×7 days or clotrimazole 1% cream ×7 days (OTC ~$8–$15 at Vermont pharmacies). For recurrent VVC (≥4 episodes/year), prescription-strength antifungals and suppressive therapy may be required — these are best managed with in-person evaluation and culture.

Fluconazole 150 mg is FDA-approved for vaginal candidiasis and is generally well tolerated. It should not be used during pregnancy — topical OTC azoles are preferred for pregnant patients who should also be seen in person. Fluconazole has drug-drug interactions with certain medications, including blood thinners, statins, and QT-prolonging drugs. TeleDirectMD reviews your medication list, allergies, and pregnancy status before prescribing. ACOG recommends re-evaluation after 2 failed courses of treatment.

Seek in-person evaluation if: symptoms don't improve within 72 hours of OTC treatment; this is your first episode or you are not certain of the diagnosis; you are pregnant; you have recurrent VVC (≥4 episodes per year); you have fever, abdominal pain, or pelvic pain (possible PID); or you may have been exposed to a sexually transmitted infection. Planned Parenthood Vermont provides in-person evaluation with sliding-scale fees at plannedparenthood.org/get-care. Vermont Title X clinics offer free or low-cost care through HHS Title X program.

Recurrent VVC is defined as four or more symptomatic episodes of VVC per year, per ACOG 2020 guidelines. RVVC affects approximately 5–8% of reproductive-age women. Evaluation requires in-person examination and vaginal culture to identify the species and guide treatment — non-albicans Candida species are more common in RVVC and are often azole-resistant. TeleDirectMD can provide initial acute episode treatment but recommends in-person evaluation for RVVC workup and suppressive therapy planning.

No. Fluconazole and topical azole antifungals are not controlled substances. They can be prescribed via Vermont telehealth without restriction. Vermont permits electronic prescribing for non-controlled medications and imposes no e-prescribing mandate. TeleDirectMD sends e-prescriptions to your chosen Vermont pharmacy — CVS, Walgreens, Rite Aid, Walmart, Safeway, or any other Vermont pharmacy — during or immediately after your visit.

Male genital yeast infections (Candida balanitis) are less common but do occur, particularly in uncircumcised men and those with diabetes or recent antibiotic use. Symptoms include redness, itching, and a rash on the glans penis. Topical OTC clotrimazole is often effective. TeleDirectMD can evaluate male genital candidiasis by video visit. Symptoms that do not resolve, recur, or involve urethral discharge warrant in-person STI testing.